These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20681998)

  • 21. Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing.
    Ibarra M CA; Wu S; Murayama K; Minami N; Ichihara Y; Kikuchi H; Noguchi S; Hayashi YK; Ochiai R; Nishino I
    Anesthesiology; 2006 Jun; 104(6):1146-54. PubMed ID: 16732084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scanning for mutations of the ryanodine receptor (RYR1) gene by denaturing HPLC: detection of three novel malignant hyperthermia alleles.
    Tammaro A; Bracco A; Cozzolino S; Esposito M; Di Martino A; Savoia G; Zeuli L; Piluso G; Aurino S; Nigro V
    Clin Chem; 2003 May; 49(5):761-8. PubMed ID: 12709367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia.
    Galli L; Orrico A; Lorenzini S; Censini S; Falciani M; Covacci A; Tegazzin V; Sorrentino V
    Hum Mutat; 2006 Aug; 27(8):830. PubMed ID: 16835904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor.
    Eltit JM; Bannister RA; Moua O; Altamirano F; Hopkins PM; Pessah IN; Molinski TF; López JR; Beam KG; Allen PD
    Proc Natl Acad Sci U S A; 2012 May; 109(20):7923-8. PubMed ID: 22547813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: evidence for a cluster of novel mutations in the C-terminal region.
    Galli L; Orrico A; Cozzolino S; Pietrini V; Tegazzin V; Sorrentino V
    Cell Calcium; 2002 Sep; 32(3):143-51. PubMed ID: 12208234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of discordance between genotype and phenotype in a malignant hyperthermia family.
    Fortunato G; Carsana A; Tinto N; Brancadoro V; Canfora G; Salvatore F
    Eur J Hum Genet; 1999; 7(4):415-20. PubMed ID: 10352931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA testing for malignant hyperthermia: the reality and the dream.
    Stowell KM
    Anesth Analg; 2014 Feb; 118(2):397-406. PubMed ID: 24445638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene.
    Deufel T; Sudbrak R; Feist Y; Rübsam B; Du Chesne I; Schäfer KL; Roewer N; Grimm T; Lehmann-Horn F; Hartung EJ
    Am J Hum Genet; 1995 Jun; 56(6):1334-42. PubMed ID: 7762556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia.
    Marchant CL; Ellis FR; Halsall PJ; Hopkins PM; Robinson RL
    Muscle Nerve; 2004 Jul; 30(1):114-7. PubMed ID: 15221887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence capture and massively parallel sequencing to detect mutations associated with malignant hyperthermia.
    Schiemann AH; Dürholt EM; Pollock N; Stowell KM
    Br J Anaesth; 2013 Jan; 110(1):122-7. PubMed ID: 23035052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling.
    Weiss RG; O'Connell KM; Flucher BE; Allen PD; Grabner M; Dirksen RT
    Am J Physiol Cell Physiol; 2004 Oct; 287(4):C1094-102. PubMed ID: 15201141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
    Ta TA; Pessah IN
    Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype.
    Sambuughin N; McWilliams S; de Bantel A; Sivakumar K; Nelson TE
    Am J Hum Genet; 2001 Jul; 69(1):204-8. PubMed ID: 11389482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of a novel mutation in the ryanodine receptor gene in an Irish malignant hyperthermia pedigree: correlation of the IVCT response with the affected and unaffected haplotypes.
    Keating KE; Giblin L; Lynch PJ; Quane KA; Lehane M; Heffron JJ; McCarthy TV
    J Med Genet; 1997 Apr; 34(4):291-6. PubMed ID: 9138151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional characterization of 2 known ryanodine receptor mutations causing malignant hyperthermia.
    Schiemann AH; Paul N; Parker R; Pollock N; Bulger TF; Stowell KM
    Anesth Analg; 2014 Feb; 118(2):375-380. PubMed ID: 24361844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Remimazolam on Intracellular Calcium Dynamics in Myotubes Derived from Patients with Malignant Hyperthermia and Functional Analysis of Type 1 Ryanodine Receptor Gene Variants.
    Miyoshi H; Otsuki S; Mukaida K; Kido K; Sumii A; Ikeda T; Noda Y; Yasuda T; Narasaki S; Kato T; Kamiya S; Horikawa YT; Tsutsumi YM
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test.
    Brandt A; Schleithoff L; Jurkat-Rott K; Klingler W; Baur C; Lehmann-Horn F
    Hum Mol Genet; 1999 Oct; 8(11):2055-62. PubMed ID: 10484775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Several Ryanodine Receptor Type 1 Gene Mutations of p.Arg2508 Are Potential Sources of Malignant Hyperthermia.
    Miyoshi H; Yasuda T; Otsuki S; Kondo T; Haraki T; Mukaida K; Nakamura R; Hamada H; Kawamoto M
    Anesth Analg; 2015 Oct; 121(4):994-1000. PubMed ID: 26381711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant hyperthermia susceptibility, an autosomal dominant disorder?
    Fagerlund TH; Islander G; Ranklev Twetman E; Berg K
    Clin Genet; 1997 Jun; 51(6):365-9. PubMed ID: 9237497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia.
    Eltit JM; Ding X; Pessah IN; Allen PD; Lopez JR
    FASEB J; 2013 Mar; 27(3):991-1000. PubMed ID: 23159934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.